(Q51565233)

7 April 2018

title

Efficacy of combined treatments in NIDDM patients with secondary failure to sulphonylureas. Is it predictable? (English)

1 reference

7 April 2018

author name string

V Trischitta

1

1 reference

7 April 2018

S Italia

2

1 reference

7 April 2018

M Raimondo

3

1 reference

7 April 2018

V Guardabasso

4

1 reference

7 April 2018

C Licciardello

5

1 reference

7 April 2018

F Runello

6

1 reference

7 April 2018

S Mazzarino

7

1 reference

7 April 2018

L Sangiorgi

8

1 reference

7 April 2018

M Anello

9

1 reference

7 April 2018

R Vigneri

10

1 reference

7 April 2018

publication date

1 December 1998

1 reference

7 April 2018

number of pages

4

1 reference

Journal of Endocrinological Investigation

inferred from page(s)

published in

1 reference

7 April 2018

volume

21

1 reference

7 April 2018

issue

11

1 reference

7 April 2018

page(s)

744-747

1 reference

7 April 2018

https://api.crossref.org/works/10.1007%2FBF03348039

1 reference

Biguanides and sulfonylureas as combination therapy in NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348039

Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348039

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348039

Comparison of Bedtime NPH or Preprandial Regular Insulin Combined With Glibenclamide in Secondary Sulfonylurea Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348039

Combination of oral antidiabetic drugs and insulin in the treatment of non-insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348039

Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348039

Bedtime insulin/daytime glipizide. Effective therapy for sulfonylurea failures in NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348039

Comparison of combined therapies in treatment of secondary failure to glyburide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348039

Morning or bedtime NPH insulin combined with sulfonylurea in treatment of NIDDM

21 January 2018

1 reference

12 December 2020

Combined metformin-sulfonylurea treatment of patients with noninsulin-dependent diabetes in fair to poor glycemic control

1 reference

12 December 2020

Treatment strategies for secondary sulfonylurea failure. Should we start insulin or add metformin? Is there a place for intermittent insulin therapy?

1 reference

12 December 2020

Sulfonylurea-metformin-combination versus sulfonylurea-insulin-combination in secondary failures of sulfonylurea monotherapy. Results of a prospective randomized study in 50 patients

1 reference

12 December 2020

Secondary failure of oral hypoglycaemic agents: frequency, possible causes, and management

1 reference

12 December 2020

The combination of insulin and oral hypoglycaemic drugs: a continuous challenge

1 reference

12 December 2020

The pharmacological treatment of hyperglycemia in NIDDM. American Diabetes Association

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03348039

1 reference

7 April 2018

1 reference

7 April 2018